ADME–Tox in drug discovery: integration of experimental and computational technologies-Reference-Cited by-同舟云学术

ADME–Tox in drug discovery: integration of experimental and computational technologies

Published:2003-09 Issue:18 Volume:8 Page:852-861
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Yu Hongshi,Adedoyin Adedayo

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference66 articles.

1. Tollman, P. et al. (2001) A Revolution in R&D. How Genomics and Genetics are Transforming the Biopharmaceutical Industry, The Boston Consulting Group

2. Benchmarking chemistry functions within pharmaceutical drug discovery and preclinical development;Rogers;Drug Disc. World. Summer,2002

3. Risks in new drug development: approval success rates for investigational drugs;Dimasi;Clin. Pharmacol. Ther.,2001

4. Managing the drug discovery/development interface;Kennedy;Drug Discov. Today,1997

5. ADME/PK as part of a rational approach to drug discovery;Eddershaw;Drug Discov. Today,2000

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Hemolytic Peptides and their Hemolytic Concentration (HC₅₀);2024-07-24

2. Molecular docking of curcumin and curcuminoids as human Zn+ dependent histone deacetylase (HDAC) enzyme inhibitors;In Silico Pharmacology;2024-05-28

3. Computer aided design of novel antibiotic drug candidate against multidrug resistant strains of Salmonella typhi from pyridine-substituted coumarins;Beni-Suef University Journal of Basic and Applied Sciences;2024-02-12

4. Integrating biocomputational techniques for Breast cancer drug discovery via the HER-2, BCRA, VEGF and ER protein targets;Computers in Biology and Medicine;2024-01

5. Metabolism Studies In Vitro and In Vivo;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024